Use of equine embryo-derived mesenchymal stromal cells and their extracellular vesicles as a treatment for persistent breeding-induced endometritis in susceptible …

FK Hollinshead, DW Hanlon, GJ Bouma… - Journal of Equine …, 2024 - Elsevier
Persistent breeding induced endometritis (PBIE) is a significant cause of infertility in mares.
The development of a safe, universal, readily available therapeutic to manage PBIE and …

Use of equine embryo-derived mesenchymal stromal cells and their extracellular vesicles as a treatment for persistent breeding-induced endometritis in susceptible …

FK Hollinshead, DW Hanlon, W Hou… - Journal of Equine …, 2024 - europepmc.org
Persistent breeding induced endometritis (PBIE) is a significant cause of infertility in mares.
The development of a safe, universal, readily available therapeutic to manage PBIE and …

Use of equine embryo-derived mesenchymal stromal cells and their extracellular vesicles as a treatment for persistent breeding-induced endometritis in susceptible …

FK Hollinshead, DW Hanlon, W Hou… - Journal of equine … - pubmed.ncbi.nlm.nih.gov
Persistent breeding induced endometritis (PBIE) is a significant cause of infertility in mares.
The development of a safe, universal, readily available therapeutic to manage PBIE and …

Use of Equine Embryo-Derived Mesenchymal Stromal Cells and Their Extracellular Vesicles as a Treatment for Persistent Breeding-Induced Endometritis in …

F Hollinshead, D Hanlon, W Hou, Z Tasma… - Available at SSRN … - papers.ssrn.com
Persistent breeding induced endometritis (PBIE) is a significant cause of infertility in mares.
The development of a safe, universal, readily available therapeutic to manage PBIE and …

Use of equine embryo-derived mesenchymal stromal cells and their extracellular vesicles as a treatment for persistent breeding-induced endometritis in susceptible …

FK Hollinshead, DW Hanlon, W Hou, Z Tasma… - 2024 - researchspace.auckland.ac.nz
Persistent breeding induced endometritis (PBIE) is a significant cause of infertility in mares.
The development of a safe, universal, readily available therapeutic to manage PBIE and …